Bain Capital Life Sciences Investors’s Omega Alpha SPAC Class A Ordinary Shares OMEG Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio OMEG Stock Details OMEG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400,000	Closed	-$3.93M	–	36
2022 Q1	$3.93M	Hold	400,000	–	–	0.38%	32
2021 Q4	$3.91M	Hold	400,000	–	–	0.31%	32
2021 Q3	$3.89M	Hold	400,000	–	–	0.24%	30
2021 Q2	$3.98M	Hold	400,000	–	–	0.26%	27
2021 Q1	$3.96M	Buy	+400,000	New	+$4.15M	0.22%	28

Other funds holding OMEG

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Bain Capital Life Sciences Investors's OMEG Position: Q2 2022 in Review

Bain Capital Life Sciences Investors sold out of Omega Alpha SPAC Class A Ordinary Shares (OMEG) in Q2 2022, closing a stake of 400,000 shares — an estimated $3.93M sold.

Bain Capital Life Sciences Investors first reported a position in OMEG in Q1 2021 and held it in 5 quarters. The position peaked at $3.98M in Q2 2021. 52 funds tracked by Wall St. Rank hold OMEG as of Q2 2022.

Bain Capital Life Sciences Investors reported no remaining Omega Alpha SPAC Class A Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Bain Capital Life Sciences Investors sold 400,000 Omega Alpha SPAC Class A Ordinary Shares shares in Q2 2022, an estimated $3.93M.
Bain Capital Life Sciences Investors first reported a position in Omega Alpha SPAC Class A Ordinary Shares in Q1 2021 and held it in 5 quarters.
Bain Capital Life Sciences Investors's Omega Alpha SPAC Class A Ordinary Shares position peaked at $3.98M in Q2 2021.
52 funds tracked by Wall St. Rank held Omega Alpha SPAC Class A Ordinary Shares as of Q2 2022.

Based on Bain Capital Life Sciences Investors's 13F filing for Q2 2022, filed 15 Aug 2022.